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Abstract
Understanding the epidemiology of pneumococcal co-colonization is important for monitoring vaccine effectiveness and
the occurrence of horizontal gene transfer between pneumococcal strains. In this study we aimed to evaluate the impact of
the seven-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal co-colonization among Portuguese children.
Nasopharyngeal samples from children up to 6 years old yielding a pneumococcal culture were clustered into three groups:
pre-vaccine era (n = 173), unvaccinated children of the vaccine era (n = 169), and fully vaccinated children (4 doses; n = 150).
Co-colonization, serotype identification, and relative serotype abundance were detected by analysis of DNA of the total
bacterial growth of the primary culture plate using the plyNCR-RFLP method and a molecular serotyping microarray-based
strategy. The plyNCR-RFLP method detected an overall co-colonization rate of 20.1%. Microarray analysis confirmed the
plyNCR-RFLP results. Vaccination status was the only factor found to be significantly associated with co-colonization: co-
colonization rates were significantly lower (p = 0.004; Fisher’s exact test) among fully vaccinated children (8.0%) than among
children from the pre-PCV7 era (17.3%) or unvaccinated children of the PCV7 era (18.3%). In the PCV7 era there were
significantly less non-vaccine type (NVT) co-colonization events than would be expected based on the NVT distribution
observed in the pre-PCV7 era (p = 0.024). In conclusion, vaccination with PCV7 resulted in a lower co-colonization rate due
to an asymmetric distribution between NVTs found in single and co-colonized samples. We propose that some NVTs
prevalent in the PCV7 era are more competitive than others, hampering their co-existence in the same niche. This result may
have important implications since a decrease in co-colonization events is expected to translate in decreased opportunities
for horizontal gene transfer, hindering pneumococcal evolution events such as acquisition of antibiotic resistance
determinants or capsular switch. This might represent a novel potential benefit of conjugate vaccines.
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Introduction
Streptococcus pneumoniae (the pneumococcus) remains a main cause
of morbidity and mortality worldwide [1]. Its ecological niche is
the human nasopharynx. Colonization by pneumococcus can
occur soon after birth and remains high in the first years of life [2].
Virtually every child is colonized by pneumococcus at some stage
in life and each serotype can colonize for several weeks being then
replaced by another serotype or reacquired [3,4].
Although poorly studied, it has been known for decades that
simultaneous carriage of multiple pneumococci (or co-colonization)
can occur [5,6]. Co-colonization is an important event for pneumo-
coccal evolution as it represents an opportunity for horizontal
gene transfer, the main mechanism of evolution in this species
[7,8].
Studies on co-colonization have been hampered by the lack of
suitable detection methods. The limited reports available have
found co-colonization rates in the range of 5–30% [3,9,10,11,12,
13,14]. However, most studies have relied on serotyping individual
colonies isolated from culture. This approach has low sensitivity, is
expensive and time-consuming and is biased to detect only the most
abundant serotypes [10,15].
In recent years, with the introduction of multivalent pneumo-
coccal conjugate vaccines, there has been a renewed interest in the
study of co-colonization since it is important to understand sero-
type changes among carriers following vaccination, for instance, to
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distinguish increased acquisition from unmasking phenomena
[16].
Simultaneously, novel approaches for detection of co-colonization
have been proposed [9,13,17,18,19]. In particular, Brugger et. al.
have developed, the plyNCR-RFLP method, based on the restriction
pattern of a highly conserved DNA region within the pneumococcal
species [9]. Additionally, Hinds et al. developed a molecular
serotyping microarray based on genomic DNA hybridization that
is able to detect and quantify all serotypes described to date [20].
In Portugal, the seven-valent pneumococcal conjugate vaccine
(PCV7) became commercially available in June 2001 and, though
the vaccine is not included in the National Immunization
Program, it has been widely prescribed as the Portuguese Society
of Pediatrics issued recommendation for PCV use among all
children up to five years of age. These included a catch up
schedule. Rates of PCV coverage increased gradually since 2001.
Estimates from Pfizer based on annual sales and considering 3.5
doses per newborn are as follows from 2001 to 2007: 17%, 32%,
56%, 65%, 63%, 75%, and 79%, respectively. In studies
conducted by us, by 2006–2007, c.a. 70% of children (aged up
to 6 years old) had received at least one PCV7 dose [21]. Major
serotype shifts have occurred since 2001 both in disease and
colonization [22,23]. Although colonization rates have remained
stable [22,23], the effect of vaccination on co-colonization has
remained unknown.
In this study, using a combination of the plyNCR-RFLP and the
molecular serotyping microarray methods, we aimed to gain
insights on the prevalence of co-colonization and evaluate
potential changes that might have occurred following vaccination
with PCV7 in Portugal.
Results
Co-colonization detected by colony morphology and by
plyNCR-RFLP
Of the 492 nasopharyngeal samples studied, two colonies with
distinct morphologies were identified in the primary selective agar
plate of 32 samples. Among these, two serotypes were isolated in
17 samples; the remaining samples yielded a single serotype. Thus,
the co-colonization rate detected by this method was 3.5%. The
plyNCR-RFLP method detected pneumococcal co-colonization in
20.1% of the 492 samples (n = 99), a significantly higher propor-
tion than the one found with the former approach (p,0.001,
X2 test).
Confirmation of co-colonization by molecular serotyping
microarray
A total of 165 samples were blindly tested using the microarray:
the 99 samples in which pneumococcal co-colonization was
detected by the plyNCR-RFLP, and 66 samples for which there
was no evidence of co-colonization. Microarray results were in
agreement with those generated by the plyNCR-RFLP method.
In addition to identifying the serotypes present in samples, the
microarray was also able to detect the presence of non-
encapsulated pneumococci and/or closely related Streptococcus
spp., collectively called non-typeables (NT). These were detected
in 40 samples, all of which had an indication of co-colonization by
the plyNCR-RFLP method. However, as both methods did not
confidently discriminate between NT species within co-colonized
samples, we decided to exclude all NT from further analysis to
avoid possible over-reporting of true pneumococcal co-coloniza-
tion. Hence, all results presented in this report involve only
pneumococci for which serotypes were identified. Still, when a
separate analysis was performed, assuming that all NT were bona
fide non-encapsulated pneumococci, the same conclusions de-
scribed below were obtained (data not shown).
Upon exclusion of all NTs, the microarray detected more than
one pneumococcal serotype (i.e. more than one capsulated strain)
in 73 samples that had an indication of co-colonization.
Confirmation of serotypes detected by the microarray
All serotypes identified by the microarray were confirmed by
PCR using as template purified DNA of the primary selective
growth. New primers, targeting specific capsule biosynthetic genes
or variants not covered by the CDC scheme, were designed as
needed (Table S1).
Factors associated with pneumococcal co-colonization
Vaccination status and attendance of day-care center F were the
only variables significantly associated with co-colonization and
both were protective factors (Table 1). Vaccinated children
presented significantly lower (p = 0.004; Fisher’s exact test) co-
colonization rates (8.0%) than non-vaccinated children (regardless
of whether the latter were from the pre-PCV7 era (17.3%) or from
the PCV7 era (18.3%)) (Figure 1).
Co-colonization patterns
Among the 73 co-colonized samples (excluding NT), the
microarray identified two serotypes in 59 samples, three serotypes
in 13 samples, and six serotypes in one sample (Table 2). When
each type of co-colonization (double, triple, and sextuple) was
analyzed separately, a higher proportion of each type of co-
colonization was still noted among the unvaccinated children.
However, probably due to the low number of observations, the
results did not reach statistical significance (Table 2).
Serotype distribution
In line with previous observations, a significant serotype
replacement effect (of vaccine types (VTs) by non-vaccine types
(NVTs)) was observed among samples from the PCV7 era
compared to samples from the pre-PCV7 era (Figure 2). This
effect was noted both in single and co-colonization events and
among vaccinated and non-vaccinated children, although it was
more pronounced in the former group.
When the relative proportion of VTs in single and co-
colonization in the pre-PCV7 and PCV7 eras were compared,
no significant changes were observed (p= 0.338, Fisher exact test).
However, this was not true for NVTs: in the PCV7 era there were
significantly less NVT co-colonization events than would be
expected based on the NVT distribution observed in the pre-
PCV7 era (p= 0.024). This result, suggested that, in the PCV7 era,
there was an asymmetric distribution among NVTs found in single
or co-colonizing events. Such effect was more pronounced among
vaccinated children (where serotype replacement effect was
strongest) leading to a decreased rate of co-colonization among
this group.
Furthermore, the distribution of individual serotypes found in
co-colonized samples reflected, in general, the distribution found
in samples containing a single strain, i.e., serotypes frequent in
single colonization tended to be also frequent in co-colonization
(Figure 3). Serotypes 19F and 23F were the most frequent
colonizers of the nasopharynx in the pre-PCV7 era and serotypes
6A and 19A dominated in the PCV7 era.
Relative abundance of serotypes of co-colonized samples
For each co-colonization event the relative proportion of each
serotype was determined by the microarray. We observed that
Pneumococcal Co-Colonization
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there was a clear dominance of one serotype over the other(s) in a
sample in 71.9% the cases involving associations of NVTs. In the
associations of two or more VTs, or VTs with NVTs, this dominance
was not so evident being 62.5% and 42.4%, respectively.
To investigate if individual serotypes had been detected in co-
colonization at a frequency significantly different from the one
expected by chance alone, a permutation analysis was done for
each time period. Serotypes 9V and 19F (in the pre-PCV7 era),
and 6A, 6C, 10A, 11A/11D, 14, 15B/C, 16F, 19A, 21, and 23A
(in the PCV7 era) were found less frequently in co-colonization
than expected (Figure 3). A more detailed analysis aimed to detect
specific associations between pairs of serotypes was not possible
due to the low numbers of each pair.
Discussion
We aimed to study the impact of PCV7 on pneumococcal co-
colonization rates by combining two recently developed methods,
ply-NCR RFLP and molecular serotyping microarray, which
enabled detection of co-colonization and the identification and
relative quantification of the serotypes present in those samples.
After excluding NT species, a co-colonization rate by capsulated
pneumococci of approximately 15%, confirmed by both the
plyNCR-RFLP and microarray methods was observed. The
combination of these two methods allowed four times more
sensitivity in detection of co-colonization than serotyping of
individual colonies exhibiting distinct morphologies.
Our results show that introduction of PCV7 led to a serotype
replacement effect among vaccinated children and, although less
pronounced, also among non-vaccinated children. As a result, in
the PCV7 era, a decrease in the proportion of VTs was observed
in single and co-colonized carriers of both groups. These findings
are in line with previous observations that indicated that, in
settings where vaccination rates are high, vaccination reduces not
only the proportion of vaccinated individuals colonized with VTs
but also among non-vaccinated individuals in the community due
to an indirect effect resulting from decreased transmission of VTs
[24].
Interestingly, co-colonization rates were significantly lower
among vaccinated children (8.0%) than among non-vaccinated
children (c.a. 18%, irrespective of whether they were from the pre-
PCV7 or PCV7 eras). Of the variables studied, attendance of day-
care center F and, more importantly, vaccination status were the
only factors that accounted for these phenomena.
Table 1. Risk factors for pneumococcal co-colonization in univariate and multivariate analysis.
Characteristic
No. of
carriers
No. (%) of
co-colonized
carriers Univariate analysis
c Multivariate analysisd
OR (95% CI) p OR (95% CI) p
Age (in months) (-)f (-)f (-)f 0.59e 0.99 [0.97–1.02] 0.60
Sex
Male 255 41 (16.1%) 1.23 [0.74–2.02] 0.45 1.18 [0.70–1.99] 0.54
Female 237 32 (13.5%) Reference Reference
Day-care center attended (out of 15) (-)f 0.15g
Unit Fh 74 4 (5.4%) 0.29 [0.10–0.82] 0.01 0.15 [0.04–0.56] 0.005
Other units 418 69 (16.5%) Reference Reference
Time period
Pre-PCV7 173 30 (17.3%) 0.74 [0.45–1.23] 0.29 1.73 [0.82–3.66] 0.15
PCV7 319 43 (13.5%) Reference Reference
Vaccination status
Unvaccinatedi 342 61 (17.8%) 0.40 [0.21–0.77] 0.004 0.34 [0.16–0.72] 0.005
Vaccinated (4 doses) 150 12 (8.0%) Reference Reference
cFisher’s exact test (Monte Carlo estimation with 10,000 simulations), except when indicated.
dMultivariate logistic regression.
eKolmogorov-Smirnov test.
fnot available for variables that are continuous or have more than two classes.
gtest applied to all day-care centers simultaneously.
hresults are only shown for unit F as the results for other units were not significant.
iincludes unvaccinated children from pre-PCV7 and PCV7 era.
doi:10.1371/journal.pone.0030235.t001
Figure 1. Frequency of co-colonization in the three study
groups.
doi:10.1371/journal.pone.0030235.g001
Pneumococcal Co-Colonization
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Comparison of the characteristics of day-care center F with the
other 14 day-care units did not reveal obvious differences between
them (in carriage prevalence, area, number of children, crowding,
or antimicrobial consumption). However, this center was enriched
on serotypes (6A, 11A/D, and 19A) known to be less associated
with co-colonization than expected by chance alone (as discussed
below) which, per se, could potentially explain this observation.
The finding that co-colonization was diminished among PCV7-
vaccinated children is of particular interest as it may have important
implications for pneumococcal evolution. Indeed, decreased co-
colonization is expected to translate in fewer opportunities for
horizontal gene transfer hindering, for example, transference of
resistance genes and emergence of vaccine escape recombinants.
But how to explain such observations? A closer inspection of
Figure 2 indicates that among vaccinated children a significant
reduction of VTs led to an asymmetric redistribution of the
proportion of single and multiple NVT carriers. Specifically, it
resulted in a higher than expected proportion of single NVT carriers
and a lower than expected proportion of NVT/NVT multiple
carriers.
One possible interpretation for the latter observation is that
some NVTs in circulation in the PCV7 era are more competitive
than others, impairing their co-existence in the same ecological
niche. Evidence for competition between serotypes in the
nasopharynx was described before and mechanisms leading to it
(such as bacteriocin production) have been identified [25,26]. Two
observations in the study support this hypothesis: (i) the fact that in
the association of two or more NVTs, there was a clear dominance
of one serotype in 71% of the cases, while such high values were
not observed in the association of two or more VTs (63%) or in the
association of VTs with NVTs (42%); and (ii) in the PCV7 era,
there were a number of NVTs that were found less frequently in
co-colonization than would be predicted by chance alone. These
serotypes were among the group of the most prevalent ones in
single colonization for the same period suggesting they are highly
competitive.
Our results contrast with those from a recent study in
Switzerland that reported a stable rate of co-colonization upon
introduction of PCV7 and a balanced co-existence of serotypes
found in co-colonized samples [27]. That study, however, differs
from ours in several aspects hindering comparisons between
findings. The study population consisted of patients with acute
otitis media or pneumonia (and hence, not healthy), children and
adults were included, colonization rates were significantly lower
(even when the same age groups were compared), and the starting
material was the swab without a culturing step. Furthermore, if
competition between serotypes is indeed relevant, local serotype
distribution may further affect the results obtained. Additional
studies are warranted to explore this subject.
Of note, we observed that in our setting (as in many others), in
the vaccine era, serotypes 6A and 19A were the most frequent
colonizers of the nasopharynx in single and co-colonization. As the
recently introduced PCV13 includes these two serotypes, it will be
important to monitor how co-colonization is affected by it.
Our study has some limitations. Firstly, it is a cross-sectional
study and therefore duration of carriage, known to vary according
to the serotype, was not taken into account [3]. This has at least
two implications: on one hand, the co-colonization rate may have
been underestimated as serotypes with shorter duration of carriage
may have been missed; on the other hand, we were unable to
determine whether the co-colonized samples result from a truly co-
existence colonization event or merely reflect a transitional state
between serotypes colonizing the nasopharynx.
Secondly, the direct culture of the nasopharyngeal swab has
some disadvantages. As with any culturing step, the chance of
Figure 2. Single and co-colonization events by vaccine-types
(VT) and non-vaccine types (NVT) in the three study groups.
*Statistically significant differences (p= 0.004; Fisher’s exact test).
doi:10.1371/journal.pone.0030235.g002
Table 2. Colonization events according to study group.
No. of serotypes
detected in samples
Pre-PCV7 era, n = 173
(%) PCV7 era
Total, n = 492
(%) p value
Unvaccinated, n = 169
(%)
Vaccinated, n = 150
(%)
1 143 (82.6) 138 (81.7) 138 (92.0) 419 (85.2) 0.018a
.1
(all co-colonization samples)
30 (17.3) 31 (18.3) 12 (8.0) 73 (14.8) 0.018a
2 25 (14.4) 23 (13.6) 11 (7.3) 59 (12.0) 0.11a
3 4 (2.3) 8 (4.7) 1 (0.7) 13 (2.6) 0.08b
4 0 (-) 0 (-) 0 (-) 0 (-) -
5 0 (-) 0 (-) 0 (-) 0 (-) -
6 1 (0.6) 0 (-) 0 (-) 1 (0.2) 0.65b
aX2 test.
bFisher’s exact test.
doi:10.1371/journal.pone.0030235.t002
Pneumococcal Co-Colonization
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occurrence of sample contamination during handling increases. In
addition, variation in the inoculum size may have occurred. This
could have been partially overcome if the swab would have been
first diluted in a liquid medium and, afterwards, a fixed amount of
the liquid sample plated. Also, the use of a cultivation step and the
choice of a selective (gentamycin blood agar) medium may have
altered the composition of the sample. Finally, the culturing step
may lead to false-negative results (as we analyzed viable cells only).
Still, despite these limitations, our strategy has the advantage of
increasing the amount of pneumococcal DNA in the samples.
Direct analysis of the swabs often leads to limited amounts of DNA
hindering further processing of the sample; for example in a
previous study using the plyNCR-RFLP method, 21% of the
samples did not yield sufficient DNA for analysis [9].
The third limitation is the current inability of the microarray to
discriminate between non-encapsulated pneumococci from other
closely related Streptococcus spp. such as S. mitis when within a
complex mixture containing other pneumococci. In this study, we
ignored the presence of these NT organisms but a separate analysis
taking into account these results mimicked the general observa-
tions reported here. However, co-colonization with non-encapsu-
lated pneumococcus or closely related species is of interest as this
represents the wider gene pool available for horizontal gene
transfer.
Finally, the inclusion of older children (up to 71 months) might
be considered a limitation as it is not clear whether conjugate
vaccines administered in the first and second year of life will have
an effect on colonization 3–4 years afterwards. Still, a previous
study by Millar et al. on the long-term effect of PCV in a
community using a 3+1 schedule, found a significantly lower
prevalence of VT carriage 27 months after vaccination when
compared with control communities [28], suggesting there might
be a prolonged effect of PCV7 on colonization. Furthermore, if we
consider the opposite scenario, that is, that children of older ages
are no longer protected by PCV7 then we would expect this group
to have higher carriage of VTs, which would lead to a net increase
in VT among the vaccinated group. This, in turn, according to our
data, would result in a global increase in co-colonization among
this group. In other words, the results presented by us for the
vaccinated group would have a bias towards an increasing co-
colonization rate. Still, the rate observed was significantly lower
than among non-vaccinated children supporting our observations
and suggesting that, if anything, the exclusion of older children
would result in a even stronger disparity between co-colonization
rates among vaccinated and unvaccinated children.
Our study has also some strength. The collection of samples
used was well defined and matched and the methods used have
high sensitivity. This allowed us to take some important
conclusions in the context of co-colonization. Finally, we are
convinced that, to our knowledge, this is one of the very few
studies to date focusing on the impact of PCV7 on pneumococcal
multiple carriage and is the first to report a significant difference
Figure 3. Individual serotype distribution of single and co-colonized samples from the pre-PCV7 and PCV7 eras. Non-vaccine
serotypes with an absolute frequency ,5 in the PCV7 era were grouped as ‘‘others’’. These include serotypes 8, 9L, 9N, 13, 15A, 17F, 18A, 18F, 19B,
19C, 22F, 24F, 29/35B, 31, 33A/33F, 34, 38, 42, 33B-like, 35A/C, 36/15B-like, and 39-lik. *Observed frequency in co-colonization is significantly lower
than expected.
doi:10.1371/journal.pone.0030235.g003
Pneumococcal Co-Colonization
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between co-colonization rates of vaccinated and non-vaccinated
children.
In summary, this study suggests that PCV7-vaccinated children
have lower rates of pneumococcal co-colonization, resulting in
decreased opportunities for horizontal gene transfer between strains.
This represents a novel potential benefit of multivalent pneumococcal
conjugate vaccines. Considering that these results may depend on
local epidemiological factors and that serotype redistribution is
occurring as novel vaccines are being introduced, additional studies
are warranted to verify if similar results are obtained.
Materials and Methods
Study design
Nasopharyngeal (NP) swabs collected from healthy children
attending day-care centers in Oeiras, Portugal, were retrospec-
tively selected [23,29]. In each year, samples were collected in the
winter months of January to March. Samples were selected
according to the following criteria: (i) swabs were obtained from
children aged 18–71 months; (ii) children had not received
antibiotic within the month preceding sampling; and (iii) swabs
yielded a pneumococcal positive culture upon direct plating within
four hours of collection as described below.
The samples were clustered in three groups matched for age
and gender: group I included samples from the pre-vaccine era
(n = 173, collected in 2001); group II included samples collected in
the vaccine era from unvaccinated children (n = 169, collected in
2006–2007); and group III included samples collected in the
vaccine era from fully vaccinated children (i.e., 4 doses, n = 150,
collected in 2006–2007) (Table S2). This study was nested in a
previous one aimed to study the impact of PCV7 on colonization
[23]. Approval for the initial study was obtained from the Ministry
of Education and directors of day-care centers. Signed informed
consent was obtained from the parents or guardians of
participating children. Samples and questionnaires were attributed
a number and all information was treated anonymously.
Isolation of pneumococci and sample preservation
NP samples were collected by pediatric nurses using mini-tip
calcium alginate sterile swabs and inoculated directly within
4 hours in a primary selective plate of 5% blood trypticase soy
agar containing gentamicin (5 mg/liter) to select for S. pneumoniae.
Plates were incubated overnight at 37uC under anaerobic
conditions, with an optochin disk. On the following day,
presumptive pneumococcal colonies exhibiting different morphol-
ogies were picked (one colony per morphology) and subcultured.
The remaining bacterial lawn was collected and frozen at 280uC
in 1ml Mueller-Hinton broth containing 30% glycerol. On the
third day, cultures derived from the isolated colonies were also
frozen. Swabs from 2001 were discarded after plating; swabs from
2006 and 2007 were stored frozen.
PCR serotyping
Pure cultures were serotyped by PCR, as described previously
[30], using primers and conditions available at http://www.cdc.
gov/ncidod/biotech/strep/pcr.htm. Strains that could not be
typed by PCR were serotyped by the Quellung reaction using
commercially available pneumococcal antisera (Statens Serum
Institute, Copenhagen, Denmark).
DNA isolation
Total DNA was isolated from 200 ml of the primary selective
culture frozen stock using the High Pure PCR Template
Preparation Kit (Roche Applied Science) according to the
manufacturer’s instructions.
plyNCR-RFLP
Detection of co-colonization was done as previously described
[9]. Briefly, the noncoding region between the pneumolysin gene
and the preceding hypothetical protein gene was amplified by
PCR. The product was separately digested with up to four
restriction enzymes: AflIII, ApoI, DdeI, and MseI. A sample was
assumed to contain more than one strain whenever the sum of the
size of the digestion fragments was higher than the size of the
undigested PCR product.
Molecular serotyping microarray
The BmG@S SP-CPSv1.4.0 microarray designed for S.
pneumoniae molecular serotyping was used following standard
protocols previously described [27]. Microarray data was statisti-
cally analyzed using a Bayesian hierarchical model to determine
the serotype, or combination of serotypes, present in the sample
and assign their relative abundance [31]. In the interpretation of
co-colonization results, a serotype was classified as dominant if its
relative abundance in the sample was $70%.
Statistical analysis
Pair-wise associations between co-colonization and vaccination
status, time period, age, gender and day-care center were
measured. Statistical significance was accessed through Fisher
exact tests. A Kolmogorov-Smirnov test was applied to compare
age distribution between multiple and single carriers. Associations
were considered significant if p,0.05.
Multivariate logistic regression models were used to detect
associations with co-colonization, using vaccination status, time
period, age, gender and day-care center as independent variables.
As day-care center was a categorical variable with more than two
categories, 14 dummy variables (binary variables for all but one
day-care center) were constructed and used.
Models were adjusted with all independent variables simulta-
neously and through backward and forward stepwise variable
selection methods (which produced the same final models). Models
were adjusted to subsets of data including only vaccine period
individuals, or excluding vaccinated individuals. Although only 73
of 492 samples were positive for co-colonization (as detailed in the
results’ section) all 492 samples were used in the multiple logistic
regression enabling the analyses of all variables under study.
Indeed, according to Peduzzi et al. [32], the size of our sample
allows models with up to 7–8 predictor variables. Furthermore,
according to the later work of Vittinghoff and McCulloch [33],
this number of predictors can safely be double if the aim of the
analysis is to detect associations in observational data and not
making predictions; or if the high number of predictors is
necessary to control possible confounding variables. Our study
fitted both conditions.
Permutation analysis was done to test if serotypes were found in
co-colonized carriers at frequencies different than expected by
chance. For each time period, serotype identifications were
randomly allocated to children (including not colonized) 2000
times. Serotype frequencies were maintained. The p-values
obtained for all serotypes were corrected for multiple testing by
controlling the False Discovery Rate below 0.05 [34].
Analyses were performed in SPSS 17.0 and in Matlab 7.7.
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Table S1 List of oligonucleotides designed for this
study.
(DOCX)
Pneumococcal Co-Colonization
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30235
Table S2 Age distribution in the three groups. Compar-
ison of age distribution in the three groups was done by a
Kolmogorov-Smirnov test using the age of each child in months.
The results were not significantly different (p = 0.614).
(DOCX)
Acknowledgments
We thank Gabriela Gomes and Isabel Gordo for stimulating discussions.
Author Contributions
Conceived and designed the experiments: RSL HL CV. Performed the
experiments: CV SB KG. Analyzed the data: RSL CV JH FP. Contributed
reagents/materials/analysis tools: RSL HL JH KM FP. Wrote the paper:
RSL CV. Critically revised the manuscript: CV JH FP SB KG KM HL
RSL.
References
1. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5
years: global estimates. Lancet 374: 893–902.
2. Bogaert D, De Groot R, Hermans PW (2004) Streptococcus pneumoniae colonisation:
the key to pneumococcal disease. Lancet Infect Dis 4: 144–154.
3. Gray BM, Converse GMd, Dillon HC, Jr. (1980) Epidemiologic studies of
Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the
first 24 months of life. J Infect Dis 142: 923–933.
4. Sa´-Lea˜o R, Nunes S, Brito-Avoˆ A, Alves CR, Carric¸o JA, et al. (2008) High rates
of transmission of and colonization by Streptococcus pneumoniae and Haemophilus
influenzae within a day care center revealed in a longitudinal study. J Clin
Microbiol 46: 225–234.
5. Griffith F (1928) The significance of pneumococcal types. J Hyg 27: 113–159.
6. Hodges RG, MacLeod CM, Bernhard WG (1946) Epidemic pneumococcal
pneumonia. III, carrier studies. Am J Hyg 44: 207–230.
7. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, et al. (1995)
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group
day care: evidence suggesting capsular transformation of the resistant strain in
vivo. J Infect Dis 171: 890–896.
8. Spratt BG, Hanage WP, Feil EJ (2001) The relative contributions of
recombination and point mutation to the diversification of bacterial clones.
Curr Opin Microbiol 4: 602–606.
9. Brugger SD, Hathaway LJ, Muhlemann K (2009) Detection of Streptococcus
pneumoniae strain cocolonization in the nasopharynx. J Clin Microbiol 47:
1750–1756.
10. Hare KM, Morris P, Smith-Vaughan H, Leach AJ (2008) Random colony
selection versus colony morphology for detection of multiple pneumococcal
serotypes in nasopharyngeal swabs. Pediatr Infect Dis J 27: 178–180.
11. Montgomery JM, Lehmann D, Smith T, Michael A, Joseph B, et al. (1990)
Bacterial colonization of the upper respiratory tract and its association with
acute lower respiratory tract infections in Highland children of Papua New
Guinea. Rev Infect Dis 12: S1006–1016.
12. O’Brien KL, Nohynek H (2003) Report from a WHOWorking Group: standard
method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr
Infect Dis J 22: e1–11.
13. Rivera-Olivero IA, Blommaart M, Bogaert D, Hermans PW, de Waard JH
(2009) Multiplex PCR reveals a high rate of nasopharyngeal pneumococcal 7-
valent conjugate vaccine serotypes co-colonizing indigenous Warao children in
Venezuela. J Med Microbiol 58: 584–587.
14. Sa´-Lea˜o R, Tomasz A, Santos Sanches I, de Lencastre H (2002) Pilot study of
the genetic diversity of the pneumococcal nasopharyngeal flora among children
attending day care centers. J Clin Microbiol 40: 3577–3585.
15. Huebner RE, Dagan R, Porath N, Wasas AD, Klugman KP (2000) Lack of
utility of serotyping multiple colonies for detection of simultaneous nasopha-
ryngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J 19:
1017–1020.
16. Lipsitch M (1999) Bacterial vaccines and serotype replacement: lessons from
Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis
5: 336–345.
17. Bronsdon MA, O’Brien KL, Facklam RR, Whitney CG, Schwartz B, et al.
(2004) Immunoblot method to detect Streptococcus pneumoniae and identify multiple
serotypes from nasopharyngeal secretions. J Clin Microbiol 42: 1596–1600.
18. da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, et al.
(2010) Revisiting pneumococcal carriage by use of broth enrichment and PCR
techniques for enhanced detection of carriage and serotypes. J Clin Microbiol
48: 1611–1618.
19. Turner P, Hinds J, Turner C, Jankhot A, Gould K, et al. (2011) Improved
detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes
by use of latex agglutination or molecular serotyping by microarray. J Clin
Microbiol 49: 1784–1789.
20. Hinds J, Gould K, Witney A, Baldry S, Lambersten L, et al. (2010) Investigation
of serotype diversity, non-typeable isolates and nasopharyngeal co-colonization
by microarray-based molecular serotyping of Streptococcus pneumoniae. 7th
International Symposium on Pneumococci and Pneumococcal Diseases
(ISPPD-7). Tel Aviv, Israel. pp 129.
21. Simo˜es AS, Pereira L, Nunes S, Brito-Avoˆ A, de Lencastre H, et al. (2011)
Clonal evolution leading to maintenance of antibiotic resistance rates among
colonizing pneumococci in the PCV7 era in Portugal. J Clin Microbiol.
22. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M (2008) Changes in
Streptococcus pneumoniae serotypes causing invasive disease with non-universal
vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol
Infect 14: 835–843.
23. Sa´-Lea˜o R, Nunes S, Brito-Avoˆ A, Fraza˜o N, Simo˜es AS, et al. (2009) Changes
in pneumococcal serotypes and antibiotypes carried by vaccinated and
unvaccinated day-care centre attendees in Portugal, a country with widespread
use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect
15: 1002–1007.
24. Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease
after pneumococcal vaccination. Lancet.
25. Claverys JP, Havarstein LS (2007) Cannibalism and fratricide: mechanisms and
raisons d’etre. Nat Rev Microbiol 5: 219–229.
26. Lipsitch M, Dykes JK, Johnson SE, Ades EW, King J, et al. (2000) Competition
among Streptococcus pneumoniae for intranasal colonization in a mouse model.
Vaccine 18: 2895–2901.
27. Brugger SD, Frey P, Aebi S, Hinds J, Muhlemann K (2010) Multiple
colonization with S. pneumoniae before and after introduction of the seven-valent
conjugated pneumococcal polysaccharide vaccine. PLoS ONE 5: e11638.
28. Millar EV, O’Brien KL, Watt JP, Bronsdon MA, Dallas J, et al. (2006) Effect of
community-wide conjugate pneumococcal vaccine use in infancy on nasopha-
ryngeal carriage through 3 years of age: a cross-sectional study in a high-risk
population. Clin Infect Dis 43: 8–15.
29. Mato R, Sanches IS, Simas C, Nunes S, Carric¸o JA, et al. (2005) Natural history
of drug-resistant clones of Streptococcus pneumoniae colonizing healthy children in
Portugal. Microb Drug Resist 11: 309–322.
30. Pai R, Gertz RE, Beall B (2006) Sequential multiplex PCR approach for
determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin
Microbiol 44: 124–131.
31. Newton R, Hinds J, Wernisch L (2011) Empirical Bayesian models for analysing
molecular serotyping microarrays. BMC Bioinformatics 12: 88.
32. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation
study of the number of events per variable in logistic regression analysis. J Clin
Epidemiol 49: 1373–1379.
33. Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable
in logistic and Cox regression. Am J Epidemiol 165: 710–718.
34. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate - a practical
and powerful approach to multiple testing. J R Stat Soc Ser B Statist Methodol
57: 289–300.
Pneumococcal Co-Colonization
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30235
